This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Channelopathies
Information about Channelopathies: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Channelopathies
Most recent studies have shown that Channelopathies shares some biological mechanisms with ataxia, brugada-syndrome-(disorder), cardiac-arrhythmia, cardiac-death, cardiomyopathies, epilepsy, heart-diseases, long-qt-syndrome, migraine-disorders, myopathy, nervous-system-disorder, nervousness, pain, periodic-paralysis-(finding), sudden-cardiac-death, sudden-death, tachycardia-ventricular, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Channelopathies, and have been seen in publications frequently: Aging, Cardiac Conduction, Cellular Localization, Cognition, Exocytosis, Hypersensitivity, Immune Response, Insulin Secretion, Ion Transport, Localization, Membrane Depolarization, Muscle Contraction, Muscle Hypertrophy, Pathogenesis, Protein Folding, Reflex, Secretion, Synaptic Transmission, Transepithelial Transport, Transport
Quite a number of genes have been found to play important roles in Channelopathies, such as AQP4, AURKA, CACNA1A, CACNA1S, CFTR, INS, KCNA1, KCNE1, KCNE2, KCNH2, KCNJ11, KCNJ2, KCNQ1, KCNQ2, SCN1A, SCN2A, SCN4A, SCN5A, SCN9A. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.